Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00515177
Status:
COMPLETED
Last Update Posted:
2013-03-29
First Post:
2007-08-10
Brief Title:
Mindfulness Versus Pharmacotherapy for Chronic Insomnia A Pilot Study
Sponsor:
University of Minnesota
Organization:
University of Minnesota
Study Overview
Official Title:
Mindfulness Versus Pharmacotherapy for Chronic Insomnia A Pilot Study
Status:
COMPLETED
Status Verified Date:
2013-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MVP1
Brief Summary:
Chronic insomnia is a major public health problem that affects about 10 of adults and is associated with serious and distressful health consequences such as depression anxiety and reduced quality of life Sleep medications are effective but side effects costs and uncertain long term efficacy call for non-pharmacologic alternatives Mindfulness-Based Stress Reduction MBSR a standardized program of training in mindfulness meditation and yoga is a promising new approach for treating chronic insomnia MBSR was developed to facilitate adaptation to the stressors of medical illness It is hypothesized that mindfulness training reduces arousal and unhelpful cognitions that promote and sustain chronic insomnia The Mindfulness Versus Pharmacotherapy trial MVP1 is a pilot study designed to establish the feasibility and determine the optimal design for a full-scale trial comparing MBSR to prescribed sleep medication for treatment of chronic insomnia For this pilot we will randomize persons with primary chronic insomnia actual sample of 30 persons to 2 groups 1 MBSR 8-weeks of group instruction followed by 3-months of home practice and 2 PCT 3 mg of LUNESTAeszopiclone nightly for 8-weeks followed by 3-months of as needed use Both groups will have telephone monitoring for side effects adherence tracking and objective sleep assessment by actigraphy The primary outcomes are sleep quality sleep quantity and insomnia severity assessed by well-validated self-report scales objective sleep parameters measured by wrist actigraphy depression and anxiety symptoms health-related quality of life and workplace productivity We hypothesize that those in the MBSR group will have improved sleep outcomes Outcomes will be assessed at 8-weeks the end of the active intervention phase and 5 months follow-up Outcomes will be compared to baseline values and measures reflecting proposed mechanisms of action to determine if clinically important impacts are likely to be obtainable in a full-scale trial After follow-up data have been collected participants will be invited to participate in focus groups to share their impressions of the study interventions to identify issues that could be addressed in a full-scale trial Our long-range goal is to provide evidence-based recommendations for safe practical and cost-effective non-pharmacologic treatment options for chronic insomnia
Detailed Description:
The NIHs 2003 National Sleep Disorders Research Plan defines insomnia as difficulty falling asleep difficulty staying asleep or short sleep duration despite adequate opportunity for sleep and estimates that it affects 30 to 40 of adults The prevalence of chronic insomnia defined as sleep disturbances for 4 weeks or more sleep disruption with daytime impairment or regular nightly sleep difficulty is about 10 of the general population with higher rates among women older adults and clinical populations Total direct and indirect costs of insomnia are estimated to be roughly 113 billion annually While only about 3 million of the 70 million Americans with insomnia take prescription medications annual prescription drug costs for insomnia exceed 21 billion dollars
Mindfulness-Based Stress Reduction MBSR a standardized group program of training in mindfulness meditation and yoga is a promising intervention for lifelong self-management of chronic insomnia Mindfulness meditation training has been found to improve sleep outcomes in patients with chronic illnesses Meditation may be defined as self-regulation of attention and mindfulness has been described as paying attention in a particular intentional way moment-by-moment without judging MBSR originated with the Stress Reduction Clinic at the University of Massachusetts Medical Center and is currently used in over 250 clinics hospitals and health maintenance organizations in the US and abroad wwwumassmededucfmsrp
MVP1 is a pilot study to establish feasibility refine procedures and determine the optimal design for a planned full-scale trial An active control drug eszopiclone which is a widely used and FDA approved prescription sleep medication is included in the pilot to provide a benchmark for efficacy Outcomes will evaluated to determine if clinically important impacts are likely to be obtainable in the future full-scale trial
Mindfulness-Based Stress Reduction MBSR a standardized group program of training in mindfulness meditation and yoga is a promising intervention for lifelong self-management of chronic insomnia Mindfulness meditation training has been found to improve sleep outcomes in patients with chronic illnesses Meditation may be defined as self-regulation of attention and mindfulness has been described as paying attention in a particular intentional way moment-by-moment without judging MBSR originated with the Stress Reduction Clinic at the University of Massachusetts Medical Center and is currently used in over 250 clinics hospitals and health maintenance organizations in the US and abroad wwwumassmededucfmsrp
MVP1 is a pilot study to establish feasibility refine procedures and determine the optimal design for a planned full-scale trial An active control drug eszopiclone which is a widely used and FDA approved prescription sleep medication is included in the pilot to provide a benchmark for efficacy Outcomes will evaluated to determine if clinically important impacts are likely to be obtainable in the future full-scale trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None